CD274 and neoplasm: Exosomal PD-L1 appears to be at the crossroads of inflammation and tumor progression, and thus, elucidating the factors and mechanisms that lead to its biogenesis and release is needed to fully understand how tumor cells harness the inflammatory response during malignant evolution.